These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27839836)

  • 1. Different antiviral effects of IFNα and IFNβ in an HBV mouse model.
    Zhou Y; Li S; Tang Z; Xu C; Huang S; Wu J; Dittmer U; Dickow J; Sutter K; Lu M; Yang D; Song J
    Immunobiology; 2017 Mar; 222(3):562-570. PubMed ID: 27839836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection.
    Song J; Zhou Y; Li S; Wang B; Zheng X; Wu J; Gibbert K; Dittmer U; Lu M; Yang D
    PLoS One; 2014; 9(3):e90977. PubMed ID: 24618716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
    Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
    Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different antiviral effects of IFNα subtypes in a mouse model of HBV infection.
    Song J; Li S; Zhou Y; Liu J; Francois S; Lu M; Yang D; Dittmer U; Sutter K
    Sci Rep; 2017 Mar; 7(1):334. PubMed ID: 28336921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells.
    Rang A; Günther S; Will H
    J Hepatol; 1999 Nov; 31(5):791-9. PubMed ID: 10580575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
    Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
    Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice.
    Duehren S; Uchida T; Tsuge M; Hiraga N; Uprichard SL; Etzion O; Glenn J; Koh C; Heller T; Cotler SJ; Oka S; Chayama K; Dahari H
    Virus Res; 2024 Nov; 349():199451. PubMed ID: 39168375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
    Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
    Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and primary application of a mouse model with hepatitis B virus replication.
    Liu FJ; Liu L; He F; Wang S; Zhou TY; Liu C; Deng LY; Tang H
    World J Gastroenterol; 2007 Oct; 13(40):5324-30. PubMed ID: 17879401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection.
    Li Y; Luo H; Hu X; Gong J; Tan G; Luo H; Wang R; Pang H; Yu R; Qin B
    Pol J Microbiol; 2024 Jun; 73(2):217-235. PubMed ID: 38905278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
    Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
    J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2.
    Wang J; Jiang D; Zhang H; Lv S; Rao H; Fei R; Wei L
    Proteomics; 2009 Mar; 9(6):1672-82. PubMed ID: 19242931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes.
    Furutani Y; Toguchi M; Shiozaki-Sato Y; Qin XY; Ebisui E; Higuchi S; Sudoh M; Suzuki H; Takahashi N; Watashi K; Wakita T; Kakeya H; Kojima S
    PLoS One; 2019; 14(6):e0216139. PubMed ID: 31188831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.
    Guo K; Shen G; Kibbie J; Gonzalez T; Dillon SM; Smith HA; Cooper EH; Lavender K; Hasenkrug KJ; Sutter K; Dittmer U; Kroehl M; Kechris K; Wilson CC; Santiago ML
    PLoS Pathog; 2020 Oct; 16(10):e1008986. PubMed ID: 33064743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
    Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
    Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
    Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
    Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression.
    Chu X; Wu B; Fan H; Hou J; Hao J; Hu J; Wang B; Liu G; Li C; Meng S
    Antiviral Res; 2016 Mar; 127():41-9. PubMed ID: 26784393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.